Evidence map›Paper›PMID 19879619›Full record

ArticleVirology2010

Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation.

Karen E Johnson, David M Knipe

Abstract read
In one paragraph

Article in Virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Herpes Simplex Virus Type 1 Interactions with the Interferon System.International journal of molecular sciences · 2020
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Herpes Simplex Virus Evasion of Early Host Antiviral Responses.Frontiers in cellular and infection microbiology · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.Advances in anatomy, embryology, and cell biology · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Karen E JohnsonDepartment of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115, USA.
David M Knipe
Harvard University · US

Funding

VIRAL AND CELLULAR GENES IN HSV LATENCY AND REACTIVATIONP01NS035138 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI SCHAFFER, PRISCILLA A · 1996 to 2010
$15.0M
Innate Immunity and Herpes Simplex InfectionP01AI083215 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FINBERG, ROBERT WILLIAM · 2009 to 2010
$3.7M
NIAID NIH HHS P01 AI083215NINDS NIH HHS P01 NS035138
6 · The paper itself

Abstract

Host cells respond to viral infection by the production of type I interferons (IFNs), which induce the expression of antiviral genes. Herpes simplex virus I (HSV-1) encodes many mechanisms that inhibit the type I IFN response, including the ICP27-dependent inhibition of type I IFN signaling. Here we show inhibition of Stat-1 nuclear accumulation in cells that express ICP27. ICP27 expression also induces the secretion of a small, heat-stable type I IFN antagonizing protein that inhibits Stat-1 nuclear accumulation. We show that the inhibition of IFN-induced Stat-1 phosphorylation occurs at or upstream of Jak-1 phosphorylation. Finally, we show that ISG15 expression is induced after IFNalpha treatment in mock-infected cells, but not cells infected with WT HSV-1 or ICP27(-) HSV-1. These data suggest that HSV-1 has evolved multiple mechanisms to inhibit IFN signaling not only in infected cells, but also in neighboring cells, thereby allowing for increased viral replication and spread.

Indexed as

Signal TransductionActive Transport, Cell NucleusAnimalsBlotting, NorthernCell NucleusChlorocebus aethiopsCytokinesFluorescent Antibody TechniqueHerpesvirus 1, HumanImmediate-Early ProteinsInterferon Type IJanus Kinase 1PhosphorylationReceptor, Interferon alpha-betaRNA, MessengerRNA SplicingCytokinesICP27 protein, human herpesvirus 1Immediate-Early ProteinsInterferon Type IISG15 protein, humanJanus Kinase 1Receptor, Interferon alpha-betaRNA, MessengerSTAT1 Transcription FactorUbiquitins

Identifiers

PMID19879619
PMCPMC2787861
OpenAlexW2069416488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.